Literature DB >> 621614

Pattern of response to prednisone in idiopathic, minimal lesion nephrotic syndrome as a criterion in selecting patients for cyclophosphamide therapy.

E H Garin, N D Pryor, R S Fennell, G A Richard.   

Abstract

Twenty-three children with idiopathic, relapsing minimal lesion nephrotic syndrome were divided according to their pattern of response to prednisone: (1) steroid dependent, if the relapse occurred while the dosage of prednisone was being decreased; and (2) frequent relapser, if the relapse occurred at variable periods of time (one week to two months) after discontinuing prednisone therapy. All patients received cyclophosphamide for eight weeks in a single daily dose of 2 mg/kg, in order to prolong the length of the remission. The percentage of patients who continued in remission at the end of the first year and thereafter was greater in the frequent relapser group (P = 0.05). This study suggests that the pattern of response to prednisone may be another criterion for the selection of patients who will benefit from cyclophosphamide therapy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 621614     DOI: 10.1016/s0022-3476(78)80032-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  B Oemar; J Brodehl
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

2.  Minimal change nephrotic syndrome and cyclophosphamide.

Authors:  R S Trompeter
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

3.  Ciclosporin treatment in children with steroid-dependent nephrotic syndrome.

Authors:  Y Kitano; N Yoshikawa; R Tanaka; H Nakamura; M Ninomiya; H Ito
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

4.  Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

Authors:  N Ueda; K Kuno; S Ito
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 5.  Management of nephrotic syndrome in childhood.

Authors:  T Melvin; W Bennett
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 6.  Immunosuppressive therapy in the nephrotic syndrome in children.

Authors:  R S Trompeter
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

7.  Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors: 
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

8.  Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.

Authors:  Jutta Gellermann; Uwe Querfeld
Journal:  Pediatr Nephrol       Date:  2004-01       Impact factor: 3.714

9.  Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome.

Authors:  R Tanaka; N Yoshikawa; Y Kitano; H Ito; H Nakamura
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

10.  Cyclophosphamide in treatment of minimal change nephrotic syndrome.

Authors:  I Shohet; J Meyerovitch; M Aladjem; H Boichis
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.